Cryosurvival of Embryos From Dysmorphic Oocytes

August 24, 2007 updated by: V.K.V. American Hospital, Istanbul
Various morphological abnormalities of human oocytes were reported to detrimentally affect embryo development. We observed development of frozen thawed embryos derived from oocytes with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic abnormalities of the oocytes were found to negatively affect cryosurvival potential of the embryos.

Study Overview

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34365
        • VKV American Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Human embryos derived from morphologically normal or abnormal mature oocytes that fertilized normally by microinjection procedure.
  • Embryos were obtained from couples who refused to freeze their supernumerary embryos after fresh embryo transfer in an assisted reproduction treatment cycle.

Exclusion Criteria:

  • Embryos obtained after microinjection to immature oocytes taht were in vitro matured in culture.
  • Embryos obtained from abnormally fertilized zygotes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Normal
Embryos derived from morphologically normal MII oocytes
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Irregular Shapes
Embryos derived from irregularly shaped oocytes.
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Large PVS
Embryos derived from oocytes with large perivitelline space.
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Dark Zona
Embryos derived from oocytes with dark zona pellucida
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Dark cytoplasm
Embryos derived from oocytes with dark cytoplasm
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Vacuolar cytoplasm
Embryos derived from oocytes with vacuolated cytoplasm
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Central granulation
Embryos derived from oocytes with centrally granulated cytoplasm
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Double extra
Embryos derived from oocytes with double extracytoplasmic abnormalities
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Double combined
Embryos derived from oocytes with any combination of one extracytoplasmic and one cytoplasmic anomaly
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Double cytoplasmic
Embryos derived from oocytes with any two cytoplasmic anomalies
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Triple extra
Embryos derived from oocytes with triple extracytoplasmic anomaly
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.
Triple combined
Embryos derived from oocytes with triple combined anomalies
Good quality human embryos were frozen - thawed and cultured to the blastocyst stage.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Basak Balaban, B.Sc., Assisted Reproduction Unit of the VKV American Hospital of Istanbul

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

August 24, 2007

First Submitted That Met QC Criteria

August 24, 2007

First Posted (Estimate)

August 27, 2007

Study Record Updates

Last Update Posted (Estimate)

August 27, 2007

Last Update Submitted That Met QC Criteria

August 24, 2007

Last Verified

August 1, 2007

More Information

Terms related to this study

Other Study ID Numbers

  • AH-05/04

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cryopreservation

Clinical Trials on Cryopreservation, thawing and blastocyst culture

3
Subscribe